Sponsored · Whitepaper

Bridging the Diversity Gap with Decentralized Trials

How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
 
The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach that begins with a patient-centric mindset, coupled with the use of mobile technology and connected health platforms, will enable research to become less reliant on site-based visits and bring equal access to new investigational therapies for all patients, regardless of geography, ethnicity, sex, or gender.

In this white paper, you will learn about:

  • The current diversity gap and limitations in clinical research
  • Barriers for underrepresented patient populations
  • Breaking barriers with patient-centric approaches and advanced technology
  • Foundations for a new clinical research model
  • Engaging and protecting patients with technology

Trending on Xconomy